Poland to Increase Tobacco Consumption Tax by 2025, E-cigarettes up 75%

Regulations by 2FIRSTS.ai
Jul.10.2024
Poland to Increase Tobacco Consumption Tax by 2025, E-cigarettes up 75%
Poland plans to gradually increase tobacco consumption taxes by 2025, with cigarettes seeing a 25% hike and e-cigarettes 75%.

According to the July 10th report from "Fakt", the Polish Ministry of Finance and Ministry of Health have been indicating that tobacco product consumption taxes will soon be adjusted. The plan is to gradually increase the tax rates, with the expectation that by 2025, consumption taxes on tobacco products will reach new highs: a 25% increase for cigarettes, a 38% increase for hand-rolled cigarettes, a 50% increase for innovative tobacco products, and a 75% increase for e-cigarettes. This major change has caused shockwaves within the industry.


In the next three years, the consumption tax on all tobacco products in Poland is set to increase, with a potential 60% rise for cigarettes, up to 90% for hand-rolled cigarettes, 85% for innovative tobacco products, and 150% for e-cigarettes. It is estimated that by 2025, these tax adjustments will raise the price of the cheapest pack of cigarettes to 20 zlotys (approximately $5.09 USD), while e-cigarettes are expected to see significant tax hikes of 75%, 50%, and 25% between 2025 and 2027.


The Chief Economist of the Polish Federation of Entrepreneurs, Łukasz Kozłowski, also expressed his concerns about the Ministry of Finance on X Service (formerly Twitter). He pointed out that the government's actions violate article 11 of the coalition agreement, which stipulates that tax changes must be notified at least six months in advance, but now the government is notifying them of the need to face additional consumption tax increases in a shorter period of time.


The Ministry of Finance believes that Polish people will not stop smoking, but will instead shift their focus to the grey market and smuggled products.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.
Oct.10
Portugal to Tax Nicotine Pouches from 2026 at €0.065 per Gram
Portugal to Tax Nicotine Pouches from 2026 at €0.065 per Gram
Portugal’s 2026 State Budget adds nicotine pouches to the IEC by inserting Article 104-D into the Excise Code’s tobacco chapter. A specific duty of €0.065/g applies from 2026, with rounding to whole grams. The Budget also defines pouches (natural nicotine, up to 12 mg, tobacco-free, oral mucosal absorption). Lusa projects €1.676B in tobacco excise for 2026; combined levies near €1.993B.
Oct.30 by 2FIRSTS.ai
Product | OXVA launches Artio 2 liquid-tobacco pod device, positioned as distinct from HNB and traditional flavored e-cigarettes
Product | OXVA launches Artio 2 liquid-tobacco pod device, positioned as distinct from HNB and traditional flavored e-cigarettes
OXVA has released its Artio 2 pod device featuring the Liquid Tobacco Intelligent (LTI) platform. It offers around 400 puffs per charge, pods equivalent to about 35 cigarettes, five tobacco and shisha flavors, and a 900mAh battery with 30-minute fast charging. The company positions the device as distinct from HNB and traditional flavored e-cigarettes.
Nov.27 by 2FIRSTS.ai
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
The U.S. FDA has set December 8, 2025, 11:59 p.m. ET as the closing date for public comments on the MRTP renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.
Nov.07 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
2Firsts Observation|U.S. Launches Largest-Ever Vape Enforcement Drive as Federal and State Authorities Tighten Regulations
2Firsts Observation|U.S. Launches Largest-Ever Vape Enforcement Drive as Federal and State Authorities Tighten Regulations
The U.S. has tightened vaping regulations nationwide. The DOJ, FDA, CBP and DEA seized millions of illegal devices in the largest-ever enforcement action. Several states introduced new laws with registries, packaging limits, and criminal penalties, signaling a shift toward institutionalized regulation and higher compliance costs.
Oct.17